Clinical trial

Oral Guanabenz for Multiple Sclerosis

NCT02423083

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-04-21

PhasePHASE1

Study timeline

Study start (unknown)2015-04-21Date precision: day

Registry last updated2019-12-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Relapsing-Remittingunresolved

Multiple Sclerosisunresolved

Interventions

GuanabenzDRUG

Sponsors & collaborators

National Institute of Neurological Disorders and Stroke (NINDS)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02423083 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.